Vergoeding 2018-2022 voor ATC-subgroep L02AE : Gonadoreline-analogen
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| L02AE01 Busereline (Suprefact ®) | 773.300 | 903.890 | 873.200 | 618.820 | 763.210 |
| L02AE02 Leuproreline (Lucrin pds ®) | 15.461.200 | 15.829.700 | 15.527.300 | 12.108.100 | 11.711.400 |
| L02AE03 Gosereline (Zoladex ®) | 12.183.900 | 13.141.800 | 13.352.700 | 12.678.500 | 13.219.800 |
| L02AE04 Triptoreline (Pamorelin ®) | 3.010.200 | 3.692.500 | 4.295.400 | 5.109.100 | 6.062.700 |
| Totaal | 31.428.600 | 33.567.890 | 34.048.600 | 30.514.520 | 31.757.110 |